Reported 0 shares, down 445,309 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 92000 |
| 2022-03-31 | 99000 |
| 2022-06-30 | 124000 |
| 2022-09-30 | 194000 |
| 2022-12-31 | 62477 |
| 2023-03-31 | 0 |
| 2023-03-31 | 1742 |
| 2023-06-30 | 721 |
| 2023-09-30 | 205 |
| 2023-12-31 | 842 |
| 2024-03-31 | 274 |
| 2024-06-30 | 134 |
| 2024-09-30 | 0 |
| 2024-09-30 | 1573 |
| 2024-12-31 | 13742 |
| 2025-03-31 | 34 |
| 2025-06-30 | 3496 |
| 2025-09-30 | 2 |
| 2025-12-31 | 0 |
| 2026-09-30 | 147 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | New | 306 | +306 (0.0%) | < 0.01% | $147 | 2026-11-13 | |
| Q4 2025 | Reduced | 0 | -1 (-100.0%) | 0 | $0 | 2026-02-13 | |
| Q3 2025 | Reduced | 1 | -1,801 (-99.9%) | < 0.01% | $2 | 2025-11-14 | |
| Q2 2025 | Added | 1,802 | +1,789 (13761.5%) | < 0.01% | $3,496 | 2025-08-15 | |
| Q1 2025 | Reduced | 13 | -2,200 (-99.4%) | < 0.01% | $34 | 2025-05-15 | |
| Q4 2024 | Added | 2,213 | +2,033 (1129.4%) | < 0.01% | $13,742 | 2025-02-14 | |
| Q3 2024 | New | 180 | +180 (0.0%) | < 0.01% | $1,573 | 2024-11-14 | |
| Q3 2024 | Reduced | 0 | -360 (-100.0%) | 0 | $0 | 2024-11-14 | |
| Q2 2024 | Reduced | 360 | -156 (-30.2%) | < 0.01% | $134 | 2024-08-14 | |
| Q1 2024 | Reduced | 516 | -60 (-10.4%) | < 0.01% | $274 | 2024-05-15 | |
| Q4 2023 | Added | 576 | +175 (43.6%) | < 0.01% | $842 | 2024-02-13 | |
| Q3 2023 | Reduced | 401 | -200 (-33.3%) | < 0.01% | $205 | 2023-11-15 | |
| Q2 2023 | Added | 601 | +175 (41.1%) | < 0.01% | $721 | 2023-08-14 | |
| Q1 2023 | New | 426 | +426 (0.0%) | < 0.01% | $1,742 | 2023-05-15 | |
| Q1 2023 | Reduced | 0 | -445,309 (-100.0%) | 0 | $0 | 2023-05-15 | |
| Q4 2022 | Added | 445,309 | +60,054 (15.6%) | < 0.01% | $62,477 | 2023-02-14 | |
| Q3 2022 | Added | 385,255 | +242,697 (170.2%) | < 0.01% | $194,000 | 2022-11-14 | |
| Q2 2022 | Added | 142,558 | +103,442 (264.4%) | < 0.01% | $124,000 | 2022-08-15 | |
| Q1 2022 | Added | 39,116 | +3,596 (10.1%) | < 0.01% | $99,000 | 2022-05-13 | |
| Q4 2021 | Added | 35,520 | +1,479 (4.3%) | < 0.01% | $92,000 | 2022-02-14 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
41 managers reported REDHILL BIOPHARMA LTD for Q1 2023.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| IFP Advisors Inc | Unchanged | 300 | 0 | < 0.01% | $2,175 | 5 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Reduced | 0 | -41,637 | 0 | $0 | 18 qtrs |
| CIBC WORLD MARKET INC | Reduced | 0 | -11,075 | 0 | $0 | 8 qtrs |
| Federation des caisses Desjardins du Quebec | Reduced | 0 | -159,217 | 0 | $0 | 6 qtrs |
| D A DAVIDSON & CO | Reduced | 0 | -10,500 | 0 | $0 | 27 qtrs |
| The Goldman Sachs Group Inc | Reduced | 0 | -17,861 | 0 | $0 | 13 qtrs |
| UBS Group AG | Reduced | 0 | -2,891 | 0 | $0 | 34 qtrs |
| ROYAL BANK OF CANADA | Reduced | 0 | -4,750 | 0 | $0 | 25 qtrs |
| Citigroup Inc | Reduced | 0 | -1,038 | 0 | $0 | 12 qtrs |
| WELLS FARGO & COMPANY MN | Reduced | 0 | -1,942 | 0 | $0 | 37 qtrs |
Filing details and methodology As reported
- Report period
- March 31, 2023
- Filed
- May 15, 2023
- Filing type
- 13F-HR
- Position type
- SPONSORED ADS
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.